REGISTRATION PATIENT DETAILS

Similar documents
REGISTRATION PATIENT DETAILS

SCNIR 1107 NE 45 th St, Suite #345 Seattle, WA REGISTRATION FORM. Reviewer s Signature: PHYSICIAN CONTACT INFORMATION

YEARLY SUMMARY PATIENT INFORMATION

8.6 Assessing nutrition, growth and development

Before completing this section please refer to previous immunisation records/annual reviews

Wiskott-Aldrich Registry Data Collection Form Patient Identification: Patient Name (first, middle, last)

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

Approaching Neutropenia in Children. SW Florida Osteopathic Medical Society: 39 th Annual Seminars in Family Practice

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Severe Congenital Neutropenia in Iran

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

By Dr. Mohamed Saad Daoud

Summer, 1999 Vol. 1 ABOUT THE SEVERE CHRONIC NEUTROPENIA (SCN) INTERNATIONAL REGISTRY

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Granulocyte-macrophage colonystimulating factors (G-CSF) Treatment for Severe Congenital Neutropenia (SCN)

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

Blood Cell Identification Graded

Leukocyte Disorders. Dr Alauldeen Mudhafar Zubair

screening procedures Disease resistant to full-dose imatinib ( 600 mg/day) or intolerant to any dose of imatinib

Notes for the 2 nd histology lab

بسم هللا الرحمن الرحيم

Pharmacy Prior Authorization

UNDERSTANDING SEVERE CHRONIC NEUTROPENIA

ADPedKD: detailed description of data which will be collected in this registry

Hematopathology Case Study

IN-VITRO FERTILIZATION WITH DONATED OOCYTES COMPREHENSIVE HISTORY OF RECIPIENT COUPLE (HUSBAND)

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

Subject ID: I N D # # U A * Consent Date: Day Month Year

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission

Myelodysplastic Syndrome: Let s build a definition

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology

Pharmacy Prior Authorization

Blood Cells Med Terms Quiz

Patient Identification: Patient Name (first, middle, last)

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

ERROR CORRECTION FORM

Study Events 2. Consent Information 3. Family History 5. Registry Visit 8. Visit Information 11. Vitals / Measures 13. Clinical History 15

Neupogen (Filgrastim)/Neulasta (Pegfilgrastim)

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed:

Hematopoiesis Simplified: Part 1 Erythropoiesis

Precocious Puberty. Disclosures. No financial disclosures 2/28/2019

2. Does the patient have a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP)?

Hematopathology Case Study

CASE 1. ARR 16 year old Ugandan male Senior 2 student No history of alcohol, no Tobacco

Blood Cell Identification Graded

Hematology 101. Rachid Baz, M.D. 5/16/2014

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)

Role of Traditional Medicine in improving quality of life in Kostmann Syndrome KAUH Case Report

LCD for Sargramostim (GM-CSF, Leukine ) (L29275)

VETERINARY HEMATOLOGY ATLAS OF COMMON DOMESTIC AND NON-DOMESTIC SPECIES COPYRIGHTED MATERIAL SECOND EDITION

Formation of Blood Cells

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

Circle Yes or Y N. [Note: requests without this information will not be accepted.] [If no, then no further questions.

Continuing Education Questions

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

The Complete Blood Count

Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Active Mycobacterial Infection.

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016

Update. Fall Issue 3

Clinician Blood Panel Results

PFIZER INC. PROTOCOL TITLE: Metabolic effects of growth hormone (Genotonorm ) in girls with Turner syndrome.

Granix. Granix (tbo-filgrastim) Description

Leukocytosis - Some Learning Points

Circle Yes or No Y N. (Note: requests without this information will not be accepted.) [If no, then no further questions.]

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

Granix. Granix (tbo-filgrastim) Description

Reduction Mammoplasty

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

Filgrastim SEDICO Recombinant human granulocyte-colony stimulating factor (rhg-csf) microgram.

Clinical & Laboratory Assessment

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Aplastic anamia & Sideroblastic anemia

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Diseases Of The Blood

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Pharmacy Prior Authorization

Protocol: CRI Registry (CRIPR) Targeted Adverse Event(ADV)

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Adolescence & Chronic disease

٢٨/٠١/١٤٣٧. Prof. M. Rushdi.

Does Morphology Matter in 2017

LAB TIME/DATE. 1. most numerous leukocyte. 3. also called an erythrocyte; anucleate formed element. 6. ancestral cell of platelets

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION

Juvenile Myelomonocytic Leukemia Pre-HCT Data

Laboratory for diagnosis of THALASSEMIA

INHERITED PANCYTOPENIA SYNDROMES Fanconi anemia Shwachman-Diamond syndrome Dyskeratosis congenita Congenital amegakaryocytic thrombocytopenia

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Functions of Blood. Transport. Transport. Defense. Regulation. Unit 6 Cardiovascular System: Blood

Transcription:

PATIENT DETAILS Person completing form: (please print) FOR REGIONAL REFERRAL CENTER USE ONLY Registration: Approved Date: / / Not approved RRC telephone contact with primary MD: Date: / / Reviewers Signature: Status: Date of Signed Consent: / / Patient: Address: City/Village: State/Province: Zip/Postal Code: Country: Parent /Legal Guardian (if applicable): Address: City/Village: State/Province: Zip/Postal Code: Country: Telephone Number:( )( ) Telephone Number:( )( ) Birth Date: Sex: M F Race: Caucasian Black Asian Other: (Specify) Neutropenia Code: Date of Onset: / / Date of Diagnosis: / / Congenital: 01 - If known: Severe Congenital Neutropenia / Kostmann Type Severe Congenital Neutropenia (Autosomal Dominant) Severe Congenital Neutropenia with Immunodeficiency Congenital White Cell Aplasia Shwachman - Diamond Glycogen Storage Disease Myelokathexis Other Cyclic: 02 - Must provide documentation of regular cycling with 3 X/week counts for 6 weeks and recurring infections. Idiopathic: 03 - Other: 04 - Please specify Anti-neutrophil Antibodies detected: Yes No Not Tested REFERRING PHYSICIAN Name: Institution Name: Institution Address: City/Village: State/Province: Country: Zip/Postal Code: Telephone Number:( )( ) Fax Number: ( )( ) 0.10

SIGNIFICANT CLINICAL HISTORY OF INFECTIONS BASELINE (PRE-GROWTH FACTOR/CYTOKINE) (An episode is a discrete occurrence with a beginning and an end) Mouth Ulcers/Gingivitis/ Periodontitis Skin Infections/ Abscess None 1-3 per Year FREQUENCY OF EPISODES 4-12 per Year >12 per Year, repeated or continuous Unknown Sinusitis Pharyngitis/Bronchitis Otitis Pneumonia Bacteremia Liver Abscess Colitis/Enteritis Peritonitis Urinary Tract Infections Other (specify) Other (specify) Other (specify) 0.20

SIGNIFICANT CLINICAL HISTORY OF NON-INFECTIOUS EVENTS Clinical Problems Problem prior to any growth factor (cytokine)? Problem while taking any growth factor (cytokine)? Is this a current problem? No Yes No Yes No Yes Splenomegaly Hepatomegaly Hematuria/ Proteinuria Glomerulonephritis Arthritis Vasculitis Malignancy (specify) Other clinical problem (specify) Other clinical problem (specify) 06Jan99 0.30

GROWTH AND DEVELOPMENT/PHYSICAL ASSESSMENT Date of Assessment: / / Height: or cm ft in Weight: or kg lb oz Spleen: Palpable cm bcm Not Palpable Not Assessed Liver: Palpable cm bcm Not Palpable Not Assessed REPRODUCTIVE ASSESSMENT Number of live births: Number of still births: Number of miscarriages/terminations: Has the Patient, or his/her partner, experienced any fertility problem? No Yes Unknown If yes, please describe nature of problem: Is patient or partner of male patient pregnant? No Yes, estimated delivery date: / / FOR PATIENTS <18YEARS, PLEASE INDICATE GROWTH AND DEVELOPMENT Please enter patient s Tanner Score: (1,2,3,4,5) Patient s growth and development 18Nov98 TANNER SCORE Stage Pubic Hair Penis Testes 1 None Preadolescent Preadolescent 2 3 4 5 Normal Abnormal * * Patients with abnormal growth and/or development should undergo appropriate endocrine evaluation. Scanty, long, slightly pigmented Darker, starts to curl, small amount Resembles adult type, less in quantity; coarse, curly Adult distribution, spread to medial surface of thighs Slight enlargement Longer Larger; glans and breadth increase in size Adult Enlarged scrotum, pink texture altered Larger Larger, scrotum dark Adult Stage Pubic Hair Breasts 1 Preadolescent Preadolescent 2 Sparse, lightly pigmented, straight medial border of labia Breast and papilla elevated as small mound, areolar diameter increased 3 4 Darker, beginning to curl, increased amount Coarse, curly abundant but less amount than in adult Breast and areola enlarged, no contour separation Areola and papilla form secondary mound 5 Adult feminine triangle, spread to medial surface of thighs Mature; nipple projects, areola part of general breast contour 0.40

TREATMENT HISTORY PREVIOUS GROWTH FACTOR (CYTOKINE) Treatment History Unknown If Yes, please list growth factor and specify brand name: G-CSF: Other Cytokine: Other Cytokine: No Previous Growth Factor Initial Discontinued 1 Start Date (list all that apply) Yes, Previous Growth Factor Comments List any problems or doses > 50 mcg/kg/day CURRENT GROWTH FACTOR (CYTOKINE) Current Growth Factor? No Yes Initial Current Dose Start Date If Yes, please list growth factor specifying brand name: Quantity Units 2 Frequency 3 G-CSF: Other Cytokine: Other Cytokine: Other, specify: Other, specify: OTHER MEDICATIONS/TREATMENTS FOR NEUTROPENIA Medication / Treatment None Past Current Steroids Gamma Globulin Bone Marrow Transplant Date: _ 1 Discontinuation Codes 1 = Ineffective 2 = Pt chose to withdraw 3 = Lost to follow-up 4 = Toxicity--specify in comments field 5 = Neutrophil recovery 6 = Death 9 = Other, specify in comments field 2 Units Code List MCG = Microgram MCG/KG = Microgram / kilogram M L = Millilitre (cc) U = Units U /M 2 = Units / meter square 3 Frequency Code List qd = Once a day qtd = Every third day bid = Twice a day qwk = Once a week tid = 3 times a day biw = Twice a week qid = 4 times a day tiw = 3 times a week qod = Every other day prn = As needed 0.50

Patient Initals: BONE MARROW AND CYTOGENETIC RESULTS AND BONE DENSITY ASSESSMENT Bone Marrow Evaluation: BONE MARROW No Yes Please attach report. Date of evaluation: / / Please send a stained and unstained slide from bone marrow aspirate, if available. If slides are not presently available, have these been requested? No Yes Expected date Registry will receive the slides: / / CYTOGENETICS Cytogenetics Evaluation: No Yes Please attach report. Have any cytogenetic abnormalities been noted in previous evaluations? No previous evaluation Date of evaluation: Unknown if previous evaluations done No: date of previous normal evaluation: / / Yes: date of previous abnormal evaluation: / / If Yes, specify abnormality: BONE DENSITY ASSESSMENT Bone Evaluation Done: No Yes Please attach report. Date of evaluation: Method: Normal Abnormal X-ray QCT DEXA Other, specify Fractures: No Yes, specify: Spontaneous OR Accidental 0.60

BASELINE HEMATOLOGY - ATTACH REPORTS (ANC<500) If it is not possible to attach reports, please complete this form. CBC s should be reported no more frequently than once per week within the 3 months prior to initiation of growth factor treatment or registration if patient is untreated. DATE DRAWN TYPE/UNITS Measurements Units 1 Measurements Units 1 Measurements Units 1 RBC x10 6 /mm 3 Hemoglobin g/dl Hematocrit % MCV fl Platelets x10 3 /mm 3 WBC x10 3 /mm 3 Absolute or Percentage A or P A or P A or P Bands/Stabs Seg. Neutrophils Neutrophils 2 Lymphocytes Monocytes Eosinophils Basophils Metamyelocytes Myelocytes Promyelocytes Myeloblasts Atypical Lymphocytes Large Unstained Cells Other (specify) 1 Complete if units are different from those stated. 2 Includes segs + bands 0.70

Patient Initals: ADDITIONAL PATIENT INFORMATION (Please complete and review with your physician before returning to the Data Coordinating Center.) ( ) Family History Unknown Relationship to Patient Mother Father Enrolled in Registry Neutropenia Living Deceased Leukemia Other Blood Disorder (specify) Brothers 1. (fill in initals 2. of all brothers) 3. 4. 5. Sisters 1. (fill in initals 2. of all sisters) 3. 4. 5. Other Affected Family Members: (indicate relationship, eg. maternal grandmother, etc.) Other Affected Family Members: (indicate relationship, eg. maternal grandmother, etc.) Are the parents of SCN patient related by blood to each other (e.g., 2 nd cousins)? No Yes, specify: 06Jan99 0.80